Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity

BACKGROUND: In mid-December 2020, Israel started a nationwide mass vaccination campaign against coronavirus disease 2019 (COVID-19). In the first few weeks, medical personnel, elderly citizens, and patients with chronic diseases were prioritized. As such, patients with primary and secondary immunode...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagin, David, Freund, Tal, Navon, Michal, Halperin, Tami, Adir, Dikla, Marom, Rotem, Levi, Inbar, Benor, Shira, Alcalay, Yifat, Freund, Natalia T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168345/
https://www.ncbi.nlm.nih.gov/pubmed/34087242
http://dx.doi.org/10.1016/j.jaci.2021.05.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168345/
https://www.ncbi.nlm.nih.gov/pubmed/34087242
http://dx.doi.org/10.1016/j.jaci.2021.05.029

Ejemplares similares